ARCHIVES

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

This article is from The Cancer Letter archive.

Vol. 32 No. 37 | October 20, 2006

Download PDF Visit The Full Archive

Related Articles

Crout, Finkel Replaced at FDA; Hayes Combine Biologics, Drugs

April 2, 1982

Four UICC Programs Available For International Research

July 10, 1981

Carbone Heads Chairmen’s Group

June 30, 1978

Upper Endoscopy Most Effective When Performed in 3-Year Intervals

July 27, 2012

Judge Rules Privacy Act Not Applicable In Bernard Fisher’s Suit Against HHA

July 5, 1996

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

April 24, 2009